Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
CGD NOTES
December 07, 2020
The SARS-COV-2/COVID-19 pandemic has created an unprecedented public health challenge, spurring a global race to develop and distribute viable vaccines. By mid-2021, there will likely be multiple licensed vaccines. Although there is an urgent need for these vaccines to be made available, several cri...
Blog Post
December 04, 2020
The COVID-19 pandemic has highlighted once again that the humanitarian business model is poorly suited to today’s world. Humanitarian action is most effective when it is demand-driven and locally owned. But the humanitarian sector remains supply-driven: oriented primarily around donor preference and...
Blog Post
November 25, 2020
As COVID-19 vaccines begin to emerge, policymakers around the world are feeling buoyant. Although governments will be the initial recipients of vaccines, their decisions on how to distribute these among their populations will be fundamental for the ultimate recipients: individuals.
Blog Post
November 20, 2020
Coordination is essential to effective humanitarian action. But as a recent policy paper argues, the cluster system struggles with persistent weaknesses. To understand the impacts of this model at the local level, Patrick Saez spoke with May Kayali, executive director of Pekawa in Iraq about her exp...
Blog Post
November 09, 2020
This morning, America (and much of the world) woke up to a snippet of terrific news: Pfizer and BioNTech announced their SARS-CoV2 vaccine candidate showed 90 percent efficacy. But for policymakers in low- and middle-income countries, today’s news offers limited cause for celebration—and the Pfizer/...